Kavallaris M - Search Results

1

N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity.

Keenan B, Finol-Urdaneta RK, Hope A, Bremner JB, Kavallaris M, Lucena-Agell D, Oliva MÁ, Díaz JF, Vine KL. Keenan B, et al. Among authors: kavallaris m. Cancer Cell Int. 2020 May 15;20:170. doi: 10.1186/s12935-020-01251-6. eCollection 2020. Cancer Cell Int. 2020. PMID: 32467666 Free PMC article.

2

P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene.

Gifford AJ, Kavallaris M, Madafiglio J, Matherly LH, Stewart BW, Haber M, Norris MD. Gifford AJ, et al. Among authors: kavallaris m. Int J Cancer. 1998 Oct 5;78(2):176-81. doi: 10.1002/(sici)1097-0215(19981005)78:2<176::aid-ijc10>3.0.co;2-9. Int J Cancer. 1998. PMID: 9754649

3

Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T-cell leukemia xenograft, LALW-2.

Norris MD, Haber M, Kavallaris M, Brian MJ, Lutze LH, White L, Stewart BW. Norris MD, et al. Among authors: kavallaris m. Cancer. 1991 Sep 1;68(5):981-7. doi: 10.1002/1097-0142(19910901)68:5<981::aid-cncr2820680512>3.0.co;2-w. Cancer. 1991. PMID: 1913492

4

Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate.

Norris MD, De Graaf D, Haber M, Kavallaris M, Madafiglio J, Gilbert J, Kwan E, Stewart BW, Mechetner EB, Gudkov AV, Roninson IB. Norris MD, et al. Among authors: kavallaris m. Int J Cancer. 1996 Mar 1;65(5):613-9. doi: 10.1002/(SICI)1097-0215(19960301)65:5<613::AID-IJC10>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8598312

5

Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.

Kavallaris M, Tait AS, Walsh BJ, He L, Horwitz SB, Norris MD, Haber M. Kavallaris M, et al. Cancer Res. 2001 Aug 1;61(15):5803-9. Cancer Res. 2001. PMID: 11479219

6

Microtubule alterations and resistance to tubulin-binding agents (review).

Drukman S, Kavallaris M. Drukman S, et al. Among authors: kavallaris m. Int J Oncol. 2002 Sep;21(3):621-8. Int J Oncol. 2002. PMID: 12168109 Review.

7

Growth inhibitory retinoid effects after recruitment of retinoid X receptor beta to the retinoic acid receptor beta promoter.

Cheung B, Yan J, Smith SA, Nguyen T, Lee M, Kavallaris M, Norris MD, Haber M, Marshall GM. Cheung B, et al. Among authors: kavallaris m. Int J Cancer. 2003 Jul 20;105(6):856-67. doi: 10.1002/ijc.11153. Int J Cancer. 2003. PMID: 12767074

8

Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.

Verrills NM, Po'uha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, Marshall GM, Gunning PW, Kavallaris M. Verrills NM, et al. Among authors: kavallaris m. J Natl Cancer Inst. 2006 Oct 4;98(19):1363-74. doi: 10.1093/jnci/djj372. J Natl Cancer Inst. 2006. PMID: 17018783

9

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.

Tommasi S, Mangia A, Lacalamita R, Bellizzi A, Fedele V, Chiriatti A, Thomssen C, Kendzierski N, Latorre A, Lorusso V, Schittulli F, Zito F, Kavallaris M, Paradiso A. Tommasi S, et al. Among authors: kavallaris m. Int J Cancer. 2007 May 15;120(10):2078-85. doi: 10.1002/ijc.22557. Int J Cancer. 2007. PMID: 17285590

10

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.

Gan PP, Pasquier E, Kavallaris M. Gan PP, et al. Among authors: kavallaris m. Cancer Res. 2007 Oct 1;67(19):9356-63. doi: 10.1158/0008-5472.CAN-07-0509. Cancer Res. 2007. PMID: 17909044

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters